These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 34076125)

  • 1. Vaccines: From Public Health to Big Business.
    Guimarães R
    Cien Saude Colet; 2021 May; 26(5):1847-1852. PubMed ID: 34076125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct from the COVID-19 crisis: research and innovation sparks in Brazil.
    Rosa MFF; da Silva EN; Pacheco C; Diógenes MVP; Millett C; Gadelha CAG; Santos LMP
    Health Res Policy Syst; 2021 Jan; 19(1):10. PubMed ID: 33478499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Covid vaccines: a look from the Collective Health.
    Guimarães R
    Cien Saude Colet; 2020 Sep; 25(9):3579-3585. PubMed ID: 32876276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccines in Brazil: historical analysis of the Sanitary registration and vaccine availability in the Brazilian Unified Health System.
    Peres KC; Buendgens FB; Prates EA; Bonetti NR; Soares L; Vargas-Peláez CM; Farias MR
    Cien Saude Colet; 2021 Nov; 26(11):5509-5522. PubMed ID: 34852086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Effectiveness of SARS-CoV-2 Vaccines in Reducing COVID-19-Related Deaths in over 75-Year-Olds, Ceará State, Brazil.
    Alencar CH; Cavalcanti LPG; Almeida MM; Barbosa PPL; Cavalcante KKS; Melo DN; de Brito Alves BCF; Heukelbach J
    Trop Med Infect Dis; 2021 Jul; 6(3):. PubMed ID: 34287384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current advances in the development of SARS-CoV-2 vaccines.
    Awadasseid A; Wu Y; Tanaka Y; Zhang W
    Int J Biol Sci; 2021; 17(1):8-19. PubMed ID: 33390829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Butantan Institute and the Brazilian AntiCOVID Vaccine.
    Guimarães R
    Cien Saude Colet; 2021 Jul; 26(7):2829-2832. PubMed ID: 34231695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Review of the Progress and Challenges of Developing a Vaccine for COVID-19.
    Sharma O; Sultan AA; Ding H; Triggle CR
    Front Immunol; 2020; 11():585354. PubMed ID: 33163000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. People's Willingness to Vaccinate Against COVID-19 Despite Their Safety Concerns: Twitter Poll Analysis.
    Eibensteiner F; Ritschl V; Nawaz FA; Fazel SS; Tsagkaris C; Kulnik ST; Crutzen R; Klager E; Völkl-Kernstock S; Schaden E; Kletecka-Pulker M; Willschke H; Atanasov AG
    J Med Internet Res; 2021 Apr; 23(4):e28973. PubMed ID: 33872185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One Year of Coronavirus Disease 2019 (COVID-19) in Brazil: A Political and Social Overview.
    Boschiero MN; Palamim CVC; Ortega MM; Mauch RM; Marson FAL
    Ann Glob Health; 2021 May; 87(1):44. PubMed ID: 34046307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine nationalism: a predicament in ending the COVID-19 pandemic.
    Lagman JDN
    J Public Health (Oxf); 2021 Jun; 43(2):e375-e376. PubMed ID: 33730161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brazil in the face of new SARS-CoV-2 variants: emergencies and challenges in public health.
    Marquitti FMD; Coutinho RM; Ferreira LS; Borges ME; Portella TP; Silva RLPD; Canton O; Poloni S; Franco C; Coelho V; Barberia L; Bolle M; Boing AC; Donalisio MR; Boing AF; Silva AAMD; Prado PI; Veras MASM; Kraenkel RA
    Rev Bras Epidemiol; 2021; 24():e210022. PubMed ID: 34105594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19: Coronavirus Vaccine Development Updates.
    Zhao J; Zhao S; Ou J; Zhang J; Lan W; Guan W; Wu X; Yan Y; Zhao W; Wu J; Chodosh J; Zhang Q
    Front Immunol; 2020; 11():602256. PubMed ID: 33424848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deciphering Vaccines for COVID-19: where do we stand today?
    Baviskar T; Raut D; Bhatt LK
    Immunopharmacol Immunotoxicol; 2021 Feb; 43(1):8-21. PubMed ID: 33054486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of Current Vaccine Development Strategies to Prevent Coronavirus Disease 2019 (COVID-19).
    Bennet BM; Wolf J; Laureano R; Sellers RS
    Toxicol Pathol; 2020 Oct; 48(7):800-809. PubMed ID: 32926660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of vaccines for SARS-CoV-2.
    Ng WH; Liu X; Mahalingam S
    F1000Res; 2020; 9():. PubMed ID: 32850116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Case Study: Analysis of Patents on Coronaviruses and Covid-19 for Technological Assessment and Future Research.
    Musyuni P; Aggarwal G; Nagpal M; Goyal RK
    Curr Pharm Des; 2021; 27(3):423-439. PubMed ID: 32693757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. India, Brazil and the human cost of sidelining science.
    Nature; 2021 May; 593(7857):7-8. PubMed ID: 33947994
    [No Abstract]   [Full Text] [Related]  

  • 20. Vaccines for neglected and emerging diseases in Brazil by 2030: the "valley of death" and opportunities for RD&I in Vaccinology 4.0.
    Homma A; Freire MDS; Possas C
    Cad Saude Publica; 2020; 36Suppl 2(Suppl 2):e00128819. PubMed ID: 33111747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.